Sector: Agricultural Chemicals · Industry: Biotechnology · Exchange: Nasdaq
Evogene Ltd., together with its subsidiaries, operates as a computational biology company in Israel, the United States, Europe, and Africa. It operates through three segments: Agriculture, Human Health, and Industrial Applications. The company engages in the agricultural activities, including seed traits and ag-chemicals activities; and design novel small molecules for drug development by utilizing ChemPass AI, a computational generative AI engine. It also focuses on the development and commercialization of castor bean seeds for industrial uses. In addition, the company medical cannabis products. It has a collaboration with LMU University Hospital Munich to develop novel therapies for hyper-inflammatory diseases driven by dysregulated neutrophil activity, including inflammatory bowel disease (IBD). The company was incorporated in 1999 and is headquartered in Rehovot, Israel.
Headquarters: Rehovot, US · Employees: 52 · Website: https://www.evogene.com
Evogene Ltd. (EVGN) is a publicly traded company in the Agricultural Chemicals sector (Biotechnology), listed on Nasdaq. Macroplane maps its supply-chain relationships, suppliers, buyers, financial health, and competitive positioning.
Macroplane tracks Evogene Ltd.'s (EVGN) supply chain. Key suppliers include Corteva, Inc. (CTVA).
Search companies · Macro trends · Industries · Product categories · Baskets